Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma

92.1K

views

158

authors

18

articles

Editorial

09 March 2021

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma

Kai-Bin Yang

,

Cheng Xu

,

Yu-Pei Chen

,

Jan Baptist Vermorken

, 1 more and

Jun Ma

2,991 views

5 citations

Editors

4

Sun Yat-sen University Cancer Center (SYSUCC)

Jan Baptist Vermorken

University of Antwerp

Sun Yat-sen University Cancer Center (SYSUCC)

Brian O'Sullivan

Princess Margaret Cancer Centre, University Health Network (UHN)

Impact

About

In recent years there have been several developments in the field of nasopharyngeal carcinoma (NPC), including major advances in the pathogenesis, prognosis, and therapy. For example, there have been several studies exploring the molecular landscape of NPC that have identified crucial genomic changes that stimulate the development and progression of the disease; mechanisms underlying EBV infection and NPC development were further revealed, and plasma EBV DNA detection has been demonstrated to be useful for NPC screening. Biomarkers such as EBV DNA, DNA methylation, miRNAs, and mRNAs also have demonstrated their prognostic value and potential clinical applications. More uplifting is the optimization of combined chemoradiotherapy, whereby induction chemotherapy followed by concurrent chemoradiotherapy may gain more benefits in the intensity-modulated radiotherapy era. Additionally, anti–PD-1 antibodies have shown promising anti-tumor activity and predictable safety profile in NPC as well. Still, more novel research is needed to further advance the development of our understanding of NPC.

This Research Topic will provide high-quality evidence regarding the pathogenesis and therapeutic strategies of nasopharyngeal carcinoma, thus helping identify the required knowledge, tools, and therapies for advancing the management of NPC to the next level. We welcome Original Research, Review, Clinical Trial and Case Report articles describing, but not limited to, the following areas:

1. EBV infection and pathogenesis of NPC
2. Genomic studies of NPC
3. Prognostic and/or predictive factors for NPC
4. Improvements of AJCC/UICC clinical staging for NPC
5. Applications of artificial intelligence and/or radiomics in NPC
6. Combined chemoradiotherapy strategies in NPC
7. Tailoring immunotherapy for NPC

In recent years there have been several developments in the field of nasopharyngeal carcinoma (NPC), including major advances in the pathogenesis, prognosis, and therapy. For example, there have been several studies exploring the molecular landscape of NPC that have identified crucial genomic changes that stimulate the development and progression of the disease; mechanisms underlying EBV infection and NPC development were further revealed, and plasma EBV DNA detection has been demonstrated to be useful for NPC screening. Biomarkers such as EBV DNA, DNA methylation, miRNAs, and mRNAs also have demonstrated their prognostic value and potential clinical applications. More uplifting is the optimization of combined chemoradiotherapy, whereby induction chemotherapy followed by concurrent chemoradiotherapy may gain more benefits in the intensity-modulated radiotherapy era. Additionally, anti–PD-1 antibodies have shown promising anti-tumor activity and predictable safety profile in NPC as well. Still, more novel research is needed to further advance the development of our understanding of NPC.

This Research Topic will provide high-quality evidence regarding the pathogenesis and therapeutic strategies of nasopharyngeal carcinoma, thus helping identify the required knowledge, tools, and therapies for advancing the management of NPC to the next level. We welcome Original Research, Review, Clinical Trial and Case Report articles describing, but not limited to, the following areas:

1. EBV infection and pathogenesis of NPC
2. Genomic studies of NPC
3. Prognostic and/or predictive factors for NPC
4. Improvements of AJCC/UICC clinical staging for NPC
5. Applications of artificial intelligence and/or radiomics in NPC
6. Combined chemoradiotherapy strategies in NPC
7. Tailoring immunotherapy for NPC

Download ebook

Share

Editors

Sun Yat-sen University Cancer Center (SYSUCC)

Jan Baptist Vermorken

University of Antwerp

Sun Yat-sen University Cancer Center (SYSUCC)

Brian O'Sullivan

Princess Margaret Cancer Centre, University Health Network (UHN)

Impact

92,071 Total views

66,888 Article views

22,613 Article downloads

2,570 Topic views

Published In

Journal Thumbnail

Frontiers in Oncology

Head and Neck Cancer

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic